Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells

References

• Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153–165. doi:10.1016/j.cmet.2006.01.004
   PubMed Web of Science ®Google Scholar
• Toft-Nielsen MB, Madsbad S, Holst JJ. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J Clin Endocrinol Metab. 2001;86(8):3853–3860. doi:10.1210/jcem.86.8.7743
   PubMedGoogle Scholar
• Otten J, Ryberg M, Mellberg C, et al. Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a paleolithic diet: a randomized controlled trial in healthy obese women. Eur J Endocrinol. 2019;180(6):417–427. doi:10.1530/EJE-19-0082
   PubMedGoogle Scholar
• Vilsbøll T, Krarup T, Deacon CF, et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes. 2001;50(3):609–613. doi:10.2337/diabetes.50.3.609
   PubMed Web of Science ®Google Scholar
• Sandoval DA, D’Alessio DA. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev. 2015;95(2):513–548. doi:10.1152/physrev.00013.2014
   PubMed Web of Science ®Google Scholar
• D’Alessio DA. What if gut hormones aren’t really hormones: DPP-4 inhibition and local action of GLP-1 in the gastrointestinal tract. Endocrinology. 2011;152(8):2925–2926. doi:10.1210/en.2011-1385
   PubMedGoogle Scholar
• Hjøllund KR, Deacon CF, Holst JJ. Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs. Diabetologia. 2011;54(8):2206–2208. doi:10.1007/s00125-011-2168-7
   PubMed Web of Science ®Google Scholar
• Salehi M, Purnell JQ. The role of glucagon-like peptide-1 in energy homeostasis. Metab Syndr Relat D. 2019;17(4):183–191. doi:10.1089/met.2018.0088
   PubMedGoogle Scholar
• Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes Obes Metab. 2018;20(suppl 0.1):5–21. doi:10.1111/dom.13129
   PubMedGoogle Scholar
• Rumsey R, Squires PE, Read NW. In vitro effects of sennoside on contractile activity and fluid flow in the perfused large intestine of the rat. Pharmacology. 1993;47(1):32–39. doi:10.1159/000139840
   PubMedGoogle Scholar
• Kobayashi M, Yamaguchi T, Odaka T, et al. Regionally differential effects of sennoside A on spontaneous contractions of colon in mice. Basic Clin Pharmacol. 2007;101(2):121–126. doi:10.1111/j.1742-7843.2007.00088.x
   Google Scholar
• Le J, Zhang X, Jia W, et al. Regulation of microbiota-GLP1 axis by sennoside A in diet-induced obese mice. Acta Pharm Sin B. 2019;9(4):758–768. doi:10.1016/j.apsb.2019.01.014
   PubMedGoogle Scholar
• Le J, Jia W, Sun Y. Sennoside A protects mitochondrial structure and function to improve high-fat diet-induced hepatic steatosis by targeting VDAC1. Biochem Bioph Res Co. 2018;500(2):484–489. doi:10.1016/j.bbrc.2018.04.108
   PubMedGoogle Scholar
• Li P, Lu Q, Jiang W, et al. Pharmacokinetics and pharmacodynamics of rhubarb anthraquinones extract in normal and disease rats. Biomed Pharmacother. 2017;91:425–435. doi:10.1016/j.biopha.2017.04.109
   PubMed Web of Science ®Google Scholar
• Reimer RA, Darimont C, Gremlich S, et al. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion. Endocrinology. 2001;142(10):4522–4528. doi:10.1210/endo.142.10.8415
   PubMed Web of Science ®Google Scholar
• Hou W, Yin J, Alimujiang M, et al. Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation. J Cell Mol Med. 2017;22(2):1316–1328. doi:10.1111/jcmm.13432
   PubMedGoogle Scholar
• Fan H, Chen W, Zhu J, et al. Toosendanin alleviates dextran sulfate sodium-induced colitis by inhibiting M1 macrophage polarization and regulating NLRP3 inflammasome and Nrf2/HO-1 signaling. Int Immunopharmacol. 2019;76:105909. doi:10.1016/j.intimp.2019.105909
   PubMedGoogle Scholar
• Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364–371. doi:10.2337/db11-1019
   PubMed Web of Science ®Google Scholar
• Kong T, Liu M, Ji B, et al. Role of the extracellular signal-regulated kinase 1/2 signaling pathway in ischemia-reperfusion injury. Front Physiol. 2019;10:1–10. doi:10.3389/fphys.2019.01038
   PubMedGoogle Scholar
• Dou M, Wu H, Zhu H, et al. Remifentanil preconditioning protects rat cardiomyocytes against hypoxia-reoxygenation injury via δ-opioid receptor mediated activation of PI3K/Akt and ERK pathways. Eur J Pharmacol. 2016;789:395–401. doi:10.1016/j.ejphar.2016.08.002
   PubMedGoogle Scholar
• Kim J, Hong S, Wu P, et al. Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels. Exp Cell Res. 2014;327(2):340–352. doi:10.1016/j.yexcr.2014.08.001
   PubMed Web of Science ®Google Scholar
• Lim GE, Huang GJ, Flora N, et al. Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology. 2009;150(2):580–591. doi:10.1210/en.2008-0726
   PubMed Web of Science ®Google Scholar
• Seljeset S, Siehler S. Receptor-specific regulation of ERK1/2 activation by members of the “free fatty acid receptor” family. J Recept Sig Transd. 2012;32(4):196–201. doi:10.3109/10799893.2012.692118
   PubMed Web of Science ®Google Scholar
• Tian L, Jin T. The incretin hormone GLP-1 and mechanisms underlying its secretion. J Diabetes. 2016;8(6):753–765. doi:10.1111/1753-0407.12439
   PubMed Web of Science ®Google Scholar
• Kuhre RE, Holst JJ, Kappe C. The regulation of function, growth and survival of GLP-1-producing L-cells. Clin Sci. 2016;130(2):79–91. doi:10.1042/CS20150154
   Google Scholar
• Mace OJ, Schindler M, Patel S. The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. J Physiol. 2012;590(12):2917–2936. doi:10.1113/jphysiol.2011.223800
   PubMed Web of Science ®Google Scholar
• Reimann F, Habib AM, Tolhurst G, et al. Glucose sensing in L cells: a primary cell study. Cell Metab. 2008;8(6):532–539. doi:10.1016/j.cmet.2008.11.002
   PubMed Web of Science ®Google Scholar